The Lancet Gastroenterology & Hepatology in conversation with
A podcast by The Lancet Group
84 Episodes
-
Matthew Akiyama on hepatitis C in prisons
Published: 4/12/2021 -
Monika Sarkar on reproductive health in women with liver disease
Published: 3/11/2021 -
Colorectal cancer risk in patients with Crohn’s disease
Published: 3/12/2020 -
Liver damage in young adults
Published: 1/17/2020 -
Treatments for IBS
Published: 1/14/2020 -
Statins and decompensated cirrhosis
Published: 11/27/2019 -
Global burden of pancreatic cancer and colorectal cancer
Published: 11/4/2019 -
Paediatric inflammatory bowel disease
Published: 9/12/2019 -
Transplanting hepatitis C-infected hearts
Published: 8/28/2019 -
Primary anastomosis as a treatment for diverticulitis
Published: 7/31/2019 -
Faecal microbiota transplantation in IBS
Published: 7/30/2019 -
Treating faecal incontinence in women
Published: 7/17/2019 -
Viral hepatitis in children & adolescents
Published: 5/23/2019 -
Whole-body MRI: the STREAMLINE trials
Published: 5/11/2019 -
A new drug for short bowel syndrome
Published: 4/5/2019 -
Eosinophilic oesophagitis endotype classification
Published: 3/9/2019 -
Acute hepatitis C
Published: 3/8/2019 -
Epidemiology of chronic liver disease
Published: 2/8/2019 -
Viral hepatitis in migrant populations
Published: 12/7/2018 -
DAA treatment for hepatitis C among people who inject drugs
Published: 10/25/2018
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.